- Home
- RGNX vs NMCO Comparison
RGNX vs NMCO Comparison
Compare RGNX & NMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- NMCO
- Stock Information
- Founded
- RGNX 2008
- NMCO 2019
- Country
- RGNX United States
- NMCO United States
- Employees
- RGNX N/A
- NMCO N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- NMCO Finance/Investors Services
- Sector
- RGNX Health Care
- NMCO Finance
- Exchange
- RGNX Nasdaq
- NMCO Nasdaq
- Market Cap
- RGNX 661.2M
- NMCO 594.1M
- IPO Year
- RGNX 2015
- NMCO N/A
- Fundamental
- Price
- RGNX $12.77
- NMCO $10.93
- Analyst Decision
- RGNX Strong Buy
- NMCO
- Analyst Count
- RGNX 7
- NMCO 0
- Target Price
- RGNX $30.00
- NMCO N/A
- AVG Volume (30 Days)
- RGNX 601.4K
- NMCO 207.6K
- Earning Date
- RGNX 11-06-2025
- NMCO 01-01-0001
- Dividend Yield
- RGNX N/A
- NMCO 5.43%
- EPS Growth
- RGNX N/A
- NMCO N/A
- EPS
- RGNX N/A
- NMCO N/A
- Revenue
- RGNX $155,782,000.00
- NMCO N/A
- Revenue This Year
- RGNX $198.02
- NMCO N/A
- Revenue Next Year
- RGNX $2.67
- NMCO N/A
- P/E Ratio
- RGNX N/A
- NMCO N/A
- Revenue Growth
- RGNX 74.95
- NMCO N/A
- 52 Week Low
- RGNX $5.04
- NMCO $8.52
- 52 Week High
- RGNX $13.93
- NMCO $11.64
- Technical
- Relative Strength Index (RSI)
- RGNX 58.75
- NMCO 58.79
- Support Level
- RGNX $12.66
- NMCO $10.67
- Resistance Level
- RGNX $13.93
- NMCO $10.82
- Average True Range (ATR)
- RGNX 0.72
- NMCO 0.12
- MACD
- RGNX -0.04
- NMCO -0.00
- Stochastic Oscillator
- RGNX 61.82
- NMCO 86.53
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About NMCO Nuveen Municipal Credit Opportunities Fund
Nuveen Municipal Credit Opps Fund is a closed-end fund. The fund's objective is to provide a high level of current income exempt from regular U.S. federal income tax and secondarily, total return. It invests in high yielding, low-to medium-quality municipal securities and uses leverage.